Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Hyperforin-Induced Activation of the Pregnane X Receptor Is Influenced by the Organic Anion-Transporting Polypeptide 2B1
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4510230
Author(s) Schäfer, Anima M.; Potterat, Olivier; Seibert, Isabell; Fertig, Orlando; Meyer Zu Schwabedissen, Henriette E.
Author(s) at UniBasel Meyer zu Schwabedissen, Henriette
Schäfer, Anima Magdalena
Potterat, Olivier
Fertig, Orlando
Seibert, Isabell
Year 2019
Title Hyperforin-Induced Activation of the Pregnane X Receptor Is Influenced by the Organic Anion-Transporting Polypeptide 2B1
Journal Molecular Pharmacology
Volume 95
Number 3
Pages / Article-Number 313-323
Mesh terms Biological Transport, drug effects; Caco-2 Cells; Cell Line, Tumor; Cytochrome P-450 CYP3A, metabolism; Drug Interactions, physiology; Estrone, analogs & derivatives, metabolism; HeLa Cells; Hep G2 Cells; Humans; Intestinal Absorption, drug effects; Organic Anion Transporters, metabolism; Phloroglucinol, analogs & derivatives, pharmacology; Pregnane X Receptor, metabolism; Promoter Regions, Genetic, drug effects; Terpenes, pharmacology
Abstract The herbal remedy St. John's wort (SJW) is used in the treatment of mild depressive symptoms and is known for its drug-drug interaction potential when enhanced expression of CYP3A4 modifies clearance of concomitantly applied substrate drugs. Hyperforin is one constituent of SJW that alters CYP3A4 expression by activation of the nuclear receptor pregnane X receptor (PXR). However, little is known about the transmembrane transport of hyperforin. One membrane protein that modulates cellular entry of drugs is the organic anion-transporting polypeptide (OATP) 2B1. It was the aim of this study to test whether hyperforin interacts with this transport protein. Transport inhibition studies and competitive counterflow experiments suggested that hyperforin is a substrate of OATP2B1. This notion was validated by showing that the presence of OATP2B1 enhanced the hyperforin-induced PXR activation in cell-based luciferase assays. Moreover, in Caco-2 cells transcellular transport of the known OATP2B1 substrate atorvastatin was changed in the presence of hyperforin, resulting in an increased efflux ratio. Eleven commercially available SJW formulations were assessed for their influence on OATP2B1-mediated transport of estrone 3-sulfate and for their impact on CYP3A4 promoter transactivation. The correlation between effect size and the hyperforin content as determined by high-performance liquid chromatography with ultraviolet detection suggested that hyperforin is the major determinant. Our results indicate an interaction between hyperforin and OATP2B1, which is not only known to contribute to hepatocellular uptake but also to intestinal absorption of its substrates. These findings extend the complexity of mechanisms that should be considered when evaluating the interaction potential of SJW preparations.
Publisher American Society for Pharmacology and Experimental Therapeutics
ISSN/ISBN 0026-895X ; 1521-0111
edoc-URL https://edoc.unibas.ch/71552/
Full Text on edoc No
Digital Object Identifier DOI 10.1124/mol.118.114066
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/30573512
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.355 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
23/04/2024